Viewing Study NCT01095120


Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2025-12-26 @ 3:10 AM
Study NCT ID: NCT01095120
Status: UNKNOWN
Last Update Posted: 2012-03-15
First Post: 2010-03-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer
Sponsor: Genta Incorporated
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module